首页> 外文期刊>Journal of cataract and refractive surgery >Excimer laser refractive correction of myopia after episcleral buckling for rhegmatogenous retinal detachment.
【24h】

Excimer laser refractive correction of myopia after episcleral buckling for rhegmatogenous retinal detachment.

机译:准分子激光屈光矫正硬膜外屈曲后的近视性眼源性视网膜脱离。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To evaluate the long-term effects of excimer laser treatment for ametropia after surgical treatment of rhegmatogenous retinal detachment (RRD) with scleral buckles. SETTING: Helsinki University Eye Hospital, Helsinki, Finland. METHODS: Ten patients (10 eyes) who had 1 or more surgeries for RRD followed by refractive surgery for myopia were retrospectively enrolled in this study and were examined after excimer laser refractive surgery. Photorefractive keratectomy (PRK) or laser in situ keratomileusis (LASIK) was performed using a Star S2 excimer laser system (Visx). The best spectacle-corrected visual acuity (BSCVA), refraction, degree of anisometropia, and topographical changes were evaluated before and after the surgeries. RESULTS: All patients were free of asthenopic symptoms after refractive surgery. At the end of the follow-up, a mean of 67 months +/- 14 (SD) after refractive surgery, 6 patients were within +/-1.0 diopter of the intended correction. Compared with previously reported cohorts of myopic patients, the achieved refraction in patients who previously had a scleral buckling procedure was worse. The postoperative refraction was stable, and corneal topography did not show induced scar formation, keratectasia, or irregular astigmatism. After refractive surgery, the BSCVA improved 1 Snellen line in 3 patients and 2 lines in 1 patient. One patient lost 1 Snellen line and another patient lost 2 lines. Four patients showed no changes. New retinal complications were not observed. CONCLUSIONS: In the long-term, PRK and LASIK were safe methods for the treatment of myopia in RRD patients after scleral buckling. The predictability of myopic LASIK/PRK may be worse than generally reported in myopic cohorts.
机译:目的:评估通过巩膜带扣手术治疗血源性视网膜脱离(RRD)后,准分子激光治疗屈光不正的长期效果。地点:芬兰赫尔辛基赫尔辛基大学眼科医院。方法:本研究回顾性研究了10例(10眼)RRD手术后进行近视屈光手术的患者(10眼),并在准分子激光屈光手术后对其进行了检查。使用Star S2准分子激光系统(Visx)进行光折射性角膜切除术(PRK)或激光原位角膜磨镶术(LASIK)。在手术前后评估最佳的眼镜矫正视力(BSCVA),屈光度,屈光参差程度和地形变化。结果:所有患者屈光手术后均无软弱症状。随访结束时,屈光手术后平均67个月+/- 14(SD),有6例患者在预期矫正度的+/- 1.0屈光度以内。与先前报道的近视患者队列相比,先前进行巩膜屈曲手术的患者的屈光性更差。术后屈光稳定,角膜地形图未显示诱发的疤痕形成,角膜扩张或不规则散光。屈光手术后,BSCVA改善了3例患者的Snellen线和1例患者的2线。一名患者丢失了1条Snellen线,另一名患者丢失了2条线。 4例患者无变化。未观察到新的视网膜并发症。结论:从长期来看,PRK和LASIK是治疗巩膜屈曲后RRD患者近视的安全方法。近视LASIK / PRK的可预测性可能比近视人群中普遍报道的要差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号